Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats
AbstractAtypical antipsychotics, such as olanzapine, are commonly prescribed to patients with schizophrenic symptoms and other psychiatric disorders. However, weight gain and metabolic disturbance cause adverse effects, impair patient compliance and limit clinical utility. Thus, a better understanding of treatment-acquired adverse effects and identification of targets for therapeutic intervention are believed to offer more clinical benefits for patients with schizophrenia. Beyond its nutritional effects, studies have indicated that supplementation of chromium brings about beneficial outcomes against numerous metabolic disorders. In this study, we investigated whether olanzapine-induced weight gain and metabolic disturbance involved chromium dynamic mobilization in a female Sprague-Dawley rat model, and whether a dietary supplement of chromium improved olanzapine-acquired adverse effects. Olanzapine medicated rats experienced weight gain and adiposity, as well as the development of hyperglycemia, hyperinsulinemia, insulin resistance, hyperlipidemia, and inflammation. The olanzapine-induced metabolic disturbance was accompanied by a decrease in hepatic Akt and AMP-activated Protein Kinase (AMPK) actions, as well as an increase in serum interleukin-6 (IL-6), along with tissue chromium depletion. A daily intake of chromium supplements increased tissue chromium levels and thermogenic uncoupling protein-1 (UCP-1) expression in white adipose tissues, as well as improved both post-olanzapine weight gain and metabolic disturbance. Our findings suggest that olanzapine medicated rats showed a disturbance of tissue chromium homeostasis by inducing tissue depletion and urinary excretion. This loss may be an alternative mechanism responsible for olanzapine-induced weight gain and metabolic disturbance. View Full-Text
Share & Cite This Article
Yang, C.-P.; Wang, Y.-Y.; Lin, S.-Y.; Hong, Y.-J.; Liao, K.-Y.; Hsieh, S.-K.; Pan, P.-H.; Chen, C.-J.; Chen, W.-Y. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats. Int. J. Mol. Sci. 2019, 20, 640.
Yang C-P, Wang Y-Y, Lin S-Y, Hong Y-J, Liao K-Y, Hsieh S-K, Pan P-H, Chen C-J, Chen W-Y. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats. International Journal of Molecular Sciences. 2019; 20(3):640.Chicago/Turabian Style
Yang, Ching-Ping; Wang, Ya-Yu; Lin, Shih-Yi; Hong, Yi-Jheng; Liao, Keng-Ying; Hsieh, Sheng-Kuo; Pan, Ping-Ho; Chen, Chun-Jung; Chen, Wen-Ying. 2019. "Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats." Int. J. Mol. Sci. 20, no. 3: 640.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.